The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Tribovax T

. Suspension for injection

Intervet Ireland LimitedVPA10996/260/001

Main Information

Trade NameTribovax T
Active SubstancesC. chauvoei
C. haemolyticum
C. haemolyticum cells
C.noyvi B
C. noyvi B cells
C.septicum CN3204 (3U/ml)
C.septicum CN368(7U/ml)
Dosage FormSuspension for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/260/001

Group Information

ATC CodeQI02AB01 clostridium
Therapeutic ClassImmunological - Inactivated Vaccine


Licence Issued14/01/2005
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back